Abstract
In recent years, drug abuse has been identified as the most important factor in the spread of the AIDS epidemic (1). In the injection drug use (IDU) population, the sharing of contaminated injection equipment is a major means of transmitting HIV-1 (2, 3), the primary etiologic agent of AIDS. Several reports suggest that the course of HIV-1 infection is accelerated and that the mortality is increased in IDU patients (4–7), although results of some studies are contradictory (8, 9). As in other AIDS risk groups, multiple co-factors have been considered as possible contributors to the development of AIDS in HIV-1-infected drug abusers (10). A special cofactor postulated to be important in this patient group has been drug-induced immunologic disturbances (11, 12). This “co-factor hypothesis” is supported by a large body of evidence from clinical studies, animal models, and in vitro investigations (reviewed in 13–19).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
P. Hartsock and S.G. Genser, eds., Longitudinal Studies of HIV Infection in Intravenous Drug Users.NIDA Research Monograph 109. GPO, Washington, D.C. (1991).
D. C. Des Jarlais, S.R. Friedman, and R.L. Stonebumer, HIV infection and intravenous drug use:Critical issues in transmission dynamics, infection outcomes and prevention, Rev Infect Dis. 10:151(1988).
E. E. Schoenbaum, D Hartel, P.A. Selwyn, R.S. Klein, K. Davenny, M. Rogers, C. Feiner, and G.Friedland. Risk factors for human immunodeficiency virus infection in intravenous drug users, New Engl. J Med. 321:874 (1989).
D. C. Des Jarlais, S.R. Friedman, M. Marmor, H. Cohen, D. Mildvan, S. Yancovitz, U. Mathur, W. El-Sadr, T.J Spira, J. Garber, S.T. Beatrice, A.S. Abdul-Quader, and J.L. Sotheran, Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users, AIDS 1:105 (1987).
R. L. Stoneburner, D.C. Des Jarlais, D. Benezra, L. GoreLlcin, J.L. Sotheran, S.R. Friedman, S. Schultz,M. Marmor, D. Mildvan, and R. Maslansky, A larger spectrum of severe HIV-1-related disease in intravenous drug users in New York City, Science242:916 (1988).
A. Munoz, V. Carey, A.J. Saah, J.P. Phair, L.A. Kingsley, J.L. Fahey, H.M. Ginzburg, and F.B. Polk,Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus, J. Acquir. Immune Defic. Syndr. 1:396 (1988).
J. D. Sobel, Acquired immunodeficiency syndrome in intravenous drug abusers, in: “Infections in Intravenous Drug Abusers,” D.P. Levine and J.D. Sobel, eds, Oxford University Press, New York (1991).
R. A. Kaslow, W.C. Blackwelder, D.G. Ostrow, D. Yerg, J. Palenicek, A.H. Coulson, and R.O.Valdiserri, No evidence for a role of alcohol or other psychoactive drugs in accelerating immunodeficiency in HIV-1-positive individuals, J. Am. Med. Assoc. 261:3424 (1989).
J. B. Margolick, A. Munoz, D. Vlahov, L. Solomon, J. Astemborski, S. Cohn, and K.E. Nelson,Changes in T-lymphocyte subsets in intravenous drug users with HIV-1 infection, J. Am. Med. Assoc. 267:1631 (1992).
D. C. Des Jarlais, “Potential co-factors in the outcome of HIV infection in intravenous drug users, in:”Longitudinal Studies of HIV Infection in Intravenous Drug Users,” P. Hastsock and S.G Genser, eds., NIDA Research Monograph, Washington, D.C. (1986).
R. L. Hubbard, M.E. Marsden, E. Cavanaugh, J.V. Rachal, and H.M. Ginzburg, Role of drug-abusetreatment in limiting the spread of AIDS, Rev. Infect Dis. 10:377 (1988).
R. M. Donahoe and A. Falek, Neuroimmunomodulation by opiates and other drugs of abuse:Relationship to HIV infection and AIDS, in: “Psychological, Neuropsychiatric, and Substance Abuse Aspects of AIDS”. T.P. Bridge, et al., eds. Raven Press, New York (1988).
R. M. Donahoe, Drug abuse and AIDS: Causes for the connection, in: “Drugs of Abuse: Chemistry,Pharmacology, Immunology, and AIDS”. P.T.K Pham, and K. Rice, eds. NIDA Research Monograph96 GPO. Washington, D.C. (1990).
M. J. Kreek, Immune function in heroin addicts and former heroin addicts in treatment: Pre-and post-AIDS epidemic, in: “Drugs of Abuse: Chemistry, Pharmacology, Immunology, and AIDS”. P.T.K. Pham and K. Rick, eds. NIDA Research Monograph 96. GPO, Washington, D.C. (1990).
H. U. Bryant, E.W. Bemton, and J.W. Holaday, Immunomodulatory effects of chronic morphinetreatment: Pharmacologic and mechanistic studies, in: “Drugs of Abuse: Chemistry, Pharmacology, Immunology, and AIDS”, P.T.K. Pham and K. Rick, eds. NIDA Research Monograph 96. GPO, Washington, D.C. (1990).
P. K. Peterson, T.W. Molitor, C.C. Chao, and B. Sharp, “Opiates and cell-mediated immunity. in:”Drugs of Abuse and Immune Function,” R.R. Watson, ed. CRC Press, Boca Raton (1990).
B. M. Bayer and C.M. Flores, Effects of morphine on lymphocyte function: Possible mechanisms of interaction, in: “Drugs of Abuse and Immune Function,” R.R. Watson, ed. CRC Press, Boca Raton(1990).
J. J. Madden and R.M. Donahoe, Opiate binding to cells of the immune system, in: “Drugs of Abuse and Immune Function,” R.R. Watson, ed. CRC Press, Boca Raton (1990).
R. Pillai, B.S. Nair and R.R. Watson, AIDS, drugs of abuse and the immune system: A complex immunotoxicological network, Arch Toxicol. 65:609 (1991).
Z. F. Rosenberg and A.S. Fauci, Immunopathogenic mechanisms of HIV infection: Cytokine induction of HIV expression, in: “HIV and the Immune System,” R.B. Gallagher, ed. Elsevier Trends Journals,Cambridge (1991).
W. L. Farrar, M. Komer and K.A. Clouse, Cytokine regulation of human immunodeficiency virus expression, Cytokine, 3:531 (1991).
T. Matsuyama, N. Kobayashi and N. Yamamoto. Cytokines and HIV infection: Is AIDS a tumor necrosis factor disease? AIDS 5:1405 (1991).
E. Henderson, T. Eisenstein, J. Jr. Meissler, J. Yang et al, Increased proliferation of HIV by heroin in vitro. Problems of Drug Dependence 1991: Proceedings of the 53rd Annual Scientific Meeting, The Committee on Problems of Drug Dependence, Inc., NIDA Research Monograph, in press.
C. Schweitzer, F. Keller, M.P. Schmitt, D. Jaeck, M. Adloff, C. Schmitt, C. Royer, A. Kirn and A.M. Aubertin, Morphine stimulates HIV replication in primary cultures of human Kupffer cells, Res. Virol. 142:189 (1991).
S. P. Squinto, D. Mondal, A.L. Block and O.M. Prakash, Morphine-induced transactivation of HIV-1 LTR in human neuroblastoma cells, AIDS Res. Human Retrovir. 6:1163 (1990).
P. K. Peterson, B.M. Sharp, G. Gekker, B. Jackson and H. H. Balfour, Jr. Opiates, human peripheral blood mononuclear cells, and HIV, Adv. Exper. Med. Biol. 288:171 (1991).
P. K. Peterson, B.M. Sharp, G. Gekker, P.S. Portoghese, K. Sannerud and H.H. Jr. Balfour, Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell co-cultures, AIDS 4:869 (1990) .
P. K. Peterson, G. Gekker, C.C. Chao, J. Verhoef and H.H. Jr. Balfour, Effects of morphine on human immunodeficiency virus-1 expression in the chronically infected cell lines, U1 and ACH-2, Immunol. Infect. Dis. 1:313 (1991).
P. K. Peterson, G. Gekker, C.C. Chao, R. Schut, T.W. Molitor and H.H. Jr. Balfour, Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell co-cultures: Involvement of transforming growth factor-ß. J. Immunol. 146:81 (1991).
C. C. Chao, S. Hu, T.W. Molitor, Y. Zhou, M.P. Murtaugh, M. Tsang and P.K. Peterson, Morphine potentiates transforming growth factor-ß release from human peripheral blood mononuclear cell cultures, J. Pharmacol. Exp Ther., in press (1992).
R. Schooley, Cytomegalovirus in the setting of infection with human immunodeficiency virus, Rev. Infect Dis. 12 (Suppl.):8 (1990).
A. Webster, Cytomegalovirus as a possible cofactor in HIV disease progression, J. Acquired Immune Defic. Syndr. 4 (Suppl.):47 (1991).
J. Laurence, Molecular interactions among herpesviruses and human immunodeficiency viruses,J.Infect. Dis. 162:338 (1990).
P. K. Peterson, G. Gekker, C.C. Chao, S. Hu, C. Edelman, H.H. Jr. Balfour and J. Verhoef, Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-α-mediated mechanism, J. Clin. Invest. 89:574 (1992).
P. K. Peterson, G. Gekker, C.C. Chao, R. Schut, J. Verhoef, C.K. Edelman, A. Erice and H. H.Balfour, Jr., Cocaine amplifies HIV-1 replication in CMV-stimulated PBMC co-cultures, J. Immunol,in press(1992).
W. L. Farrar, Evidence for the common expression of neuroendocrine hormones and cytokines in the immune and central nervous systems, Brain Behav Immun. 2:322 (1988).
K. Frei and A. Fontana, Immune regulatory functions of astrocytes and microglial cells within the central nervous system. in: “Physiology and Diseases. Neuroimmune Networks”, Alan R. Liss, Inc.(1989).
S. L. Hauser and T. Hayashi, Major histocompatibility complex antigens and the nervous system, in:“Physiology and Diseases. Neuroimmune Networks“, Alan R. Liss, Inc. (1989).
J. E. Merrill, Lymphokines and glial cells: Implications for disease, in: “Peripheral Signaling of the Brain“. R.C.A. Frederickson, J.L. McGaugh, and D.L. Feiten, eds. Hofgrefe & Huber Publishers,Toronto (1991).
R. W. Price, B. Brew, J. Sidtis, M. Rosenblum, A.C. Scheck and P. Cleary, The brain in AIDS: Central nervous system HIV-1 infection and AIDS dementia complex, Science 239:586 (1988) .
D. D. Ho, D.E. Bredesen, H.V. Vinters and E.S. Daar, The acquired immunodeficiency syndrome (AIDS) dementia complex, Ann. Intern Med. 111:400 (1989).
D. H. Gabuzda and R.T. Johnson, Nervous system infection with human immunodeficiency virus:Biology and pathogenesis, Curr. Asp. Neurosci. 1:285 (1990).
R. T. Johnson, J.C. McArthur and O. Narayan, The neurobiology of human immunodeficiency virus infections. FASEBI 2:2970 (1988).
D. W. Dickson, L.A. Mattiace, K. Kure, K. Hutchins, W.D. Lyman and C.F. Brosnan, Microglia in human disease, with an emphasis on acquired immune deficiency syndrome, Lab. Invest. 64:135(1991).
J. E. Merrill and I.S.Y. Chen, HIV-1, macrophages, glial cells and cytokines in AIDS nervous system disease, FASEB J. 5:2391 (1991).
C. Cheng-Mayer, J.T. Rutka, M.L. Rosenblum, T. McHugh, D.P. Stites and JA. Levy, Human immunodeficiency virus can productively infect cultured human glial cells, Proc. Natl. Acad. Sci.84:3526 (1987).
C. C. Chao, S. Hu, K. Close, C.S. Choi, T.W. Molitor, W.J. Novick and P.K. Peterson, Cytokine release from microglia: Differential inhibition by pentoxifylline and dexamethasone, J. Infect. Dis. in press(1992).
I. Y. Chung and E.N. Benveniste, Tumor necrosis factor-a production by astrocytes: Induction by lipopolysaccharide, IFN-y, and IL-1ß, J. Immunol. 144:2999 (1990).
P. K. Peterson, C.C. Chao, S. Hu and E.G. Shaskan, Glioblastoma, transforming growth and Candida meningitis: A potential link, Am. J. Med. 92:262 (1992).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer Science+Business Media New York
About this chapter
Cite this chapter
Peterson, P.K., Gekker, G., Schut, R., Hu, S., Balfour, H.H., Chao, C.C. (1993). Enhancement of HIV-1 Replication by Opiates and Cocaine: The Cytokine Connection. In: Friedman, H., Klein, T.W., Specter, S. (eds) Drugs of Abuse, Immunity, and AIDS. Advances in Experimental Medicine and Biology, vol 335. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2980-4_26
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2980-4_26
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6297-5
Online ISBN: 978-1-4615-2980-4
eBook Packages: Springer Book Archive